Viewing Study NCT05024058


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2025-12-25 @ 10:15 PM
Study NCT ID: NCT05024058
Status: TERMINATED
Last Update Posted: 2024-06-18
First Post: 2021-08-23
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Sponsor: Novartis Pharmaceuticals
Organization: